ImmunityBio (26CA.F) Q3 2024 Earnings

12AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-0.33
-0.27
-0.21
-0.15

Details

Expected EPS
-0.1463072
Actual EPS
-0.18288400000000002
Surprise EPS
-0.04
Surprise Percent
+25%

Description

ImmunityBio (26CA.F) has reported earnings of -0.18288400000000002 per share for Q3 2024.

0 Comments

Share your thoughts